This inventor holds 1 USPTO granted patent. Top assignees: Helwan University, King Abdulaziz University, University of Jeddah. Active years: 2025.
Company Filing History:
1 out of 1 
1 out of 588 
1 out of 12 Years Active: 2025
Title: Innovations of Samar S Fatahala in Breast Cancer Treatment
Introduction
Samar S Fatahala is an accomplished inventor based in Cairo, Egypt. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of breast cancer. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Samar S Fatahala holds a patent for "Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer." This patent describes compounds belonging to the group of N-benzyl-2-(4-(4-substituted-1H-1,2,3-triazol-1-yl)phenylacetamides, which exhibit cytotoxic activities against MCF7 breast cancer cells. These compounds are useful in therapeutic regimes for breast cancer and have beneficial effects on BAX, BCL-2, MCL-1, and MAPK pathways within MCF7 breast cancer cells.
Career Highlights
Throughout his career, Samar has worked with prestigious institutions such as the University of Jeddah and King Abdulaziz University. His experience in these academic environments has allowed him to collaborate with other professionals and contribute to groundbreaking research in the field of cancer treatment.
Collaborations
Samar has collaborated with notable coworkers, including Roaa M Alreemi and Hind A Alkhatabi. These partnerships have enriched his research and expanded the impact of his innovations in the medical community.
Conclusion
Samar S Fatahala's contributions to breast cancer treatment through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work continues to inspire future research and development in the field of pharmaceuticals.